IN SILICO DOCKING ANALYSIS OF BIOACTIVE COMPOUNDS FROM CALOPHYLLUM INOPHYLLUM L. ETHANOL LEAF EXTRACT AGAINST EGFR PROTEIN
Objective: The objective of this study was to evaluate the effective new phytocomponents from Calophyllum inophyllum ethanol leaf extract against breast cancer target protein of Epidermal Growth Factor Receptor (EGFR) using in silico docking studies.
Materials and Methods: The identification of compounds was done by GC-MS analysis. The in silico docking studies were carried out using Discovery Studio 4.0 software.
Results: The GC-MS analysis of ethanol leaf extract revealed the presence of eleven compounds. The docking analysis have exhibited moderate to potent inhibition with a range of dock score 3 to 55. 2H-Benzo(cd) pyrene-2,6(1,H)-dione, 3,5,7,10-tetrahydroxy-compound showed the dock score of 55.427.
Conclusion: The results revealed out that the compounds present in Calophyllum inophyllum can inhibit the EGFR protein. The plant possesses anticancer potential because of the various bioactive compounds presence which is mainly responsible for anticancer activity.
2. Normanno N, Bianco C, Strizzi L, Mancino M, Maiello MR, De Luca A, et al. The ErbB receptors and their ligands in cancer: An overview. Curr Drug Targets 2005;6(3):243-57.
3. Erlotinib BP. A new therapeutic approach for non-small cell lung cancer. Exp Opin Investig Drugs 2003;12(8):1395-401.
4. Efferth T, Sauerbrey A, Halatsch ME, Ross DD, Gebhart E. Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines. Naunyn Schmiedebergs Arch Pharmacol 2003;367(1):56-67.
5. Saravanan R, Dhachinamoorthi D, Senthilkumar K, Thamizhvanan K. Antimicrobial activity of various extracts from various parts of Calophyllum inophyllum L. J Appl Pharm Sci 2011;1(3):102-6.
6. Jaikumar K, Mohamed MS, Anand D, Saravanan P. Anticancer activity of Calophyllum inophyllum L. Ethanolic leaf extract in MCF human breast cell lines. Int J Pharm Sci Res 2016;7(8):3330-5.
7. Baig MD, Basheeruddin S, Silpa S, Reddy AV. Anti-inflammatory activity of ethanolic extracts of leaf and stem bark of Calophyllum inophyllum on albino wistar rats. Int J Pharm Sci Drug Res 2014;6(2):174-7.
8. Chen GY, Guo-Zhu Z, Han CR, ZhaoJ, Song XP, Fong WF. A new pyranoxanthone from the stems of Calophyllum membranaceum. ARKIVOC 2008;13:249-54.
9. Baig MD, Uddin SB, Begum A. Comparative analgestic studies of leaf and stem bark of Calophyllum inophyllum in Swiss albino mice. Int J Pharm Pharm 2014;6(7):348-50.
10. Anand D, Wyson WJ, Saravanan P, Rajarajan S. Phytochemical analysis of leaf extract of Eclipta alba (L.) Hassk by GC-MS Method. Int J Pharmacog Phytochem Res 2014;6(3):562-6.
11. Kumar PP, Kumaravel S, Lalitha C. Screening of antioxidant activity, total phenolics and GC-MS study of Vitex negundo. Afr J Biochem Res 2010;4:191-5.
12. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliver Rev 2001;46(1-3):3-26.
13. Usha T, Tripathi P, Pande V, Middha SK. Molecular docking and quantum mechanical studies on pelargonidin-3-glucoside as renoprotective ACE inhibitor. Comput Biol 2013;2013: Article ID: 428378, 4.
14. Selick HE, Beresford AP, Tarbit MH. The emerging importance of predictive ADME simulation in drug discovery. Drug Discov Today 2002;7(2):109-16.
15. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res 2000;28(1):235-42.
16. Suri C, Naik PK. Elucidating the precise interaction of reduced and oxidized states of neuroglobin with Ubc12 and Cop9 using molecular mechanics studies. Int J Fundam Appl Sci 2012;1(4):74-7.
17. Rao SN, Head MS, Kulkarni A, Lalonde JM. Validation studies of the site-directed docking program LibDock. J Chem Inf Model 2007;47:2159-71.
18. Malarvizhi P, Ramakrishnan N. GC-MS analysis of biologically active compounds in leaves of Calophyllum inophyllum L. Int J ChemTech Res 2011;3(2):806-9.
19. Brooks BR, Brooks CL, Mackerell AD, Nilsson L, Petrella RJ, Roux B, et al. CHARMM: The bio-molecular simulation program. Comput Chem 2009;30(10):1545-615.
20. Madeswaran A, Umamaheswari M, Asokkumar K, Sivashanmugam T, Subhadradevi V, Jagannath P. Computational drug discovery of potential phosphodiesterase inhibitors using in silico studies. Asian Pac J Trop Dis 2012;2(2):S822-6.
21. Giles D, Prabha S, Basavarajaswamy PM. Design of COX-2 inhibitors - An in silico approach. Int J Pharm Pharm Sci 2015;7(9):46-50.
22. Muegge I. PMF scoring revisited. J Med Chem 2006;49(20):5895-902.
23. Mukund S, Sivasubramanian V, Senthilkumar NS. In-silico studies on metabolites of Phormidium fragile against colon cancer EGFR protein. J Algal Biomass Util 2014;5(3):16-22.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.